US 9402820
Use of pyruvate or succinate to enhance the efficacy of a hypoxia activated prodrug for the treatment of tumors
granted A61KA61K31/19A61K31/355
Quick answer
US patent 9402820 (Use of pyruvate or succinate to enhance the efficacy of a hypoxia activated prodrug for the treatment of tumors) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/19, A61K31/355, A61K45/06